{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:11:23Z","timestamp":1794971483529,"version":"4.9.1"},"reference-count":29,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Centroderm GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Actinic keratosis (\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      ) severity is currently evaluated by subjective assessment of patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To develop and perform an initial pilot validation of a new easy\u2010to\u2010use quantitative tool for assessing\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      severity on the head.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The actinic keratosis area and severity index (\n                      <jats:styled-content style=\"fixed-case\">AKASI<\/jats:styled-content>\n                      ) for the head was developed based on a review of other severity scoring systems in dermatology, in particular the psoriasis area and severity index (\n                      <jats:styled-content style=\"fixed-case\">PASI<\/jats:styled-content>\n                      ). Initial validation was performed by 13 physicians assessing\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      severity in 18\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      patients and two controls using a physician global assessment (\n                      <jats:styled-content style=\"fixed-case\">PGA<\/jats:styled-content>\n                      ) and\n                      <jats:styled-content style=\"fixed-case\">AKASI<\/jats:styled-content>\n                      . To determine an\n                      <jats:styled-content style=\"fixed-case\">AKASI<\/jats:styled-content>\n                      score, the head was divided into four regions (scalp, forehead, left\/right cheek ear, chin and nose). In each region, the percentage of the area affected by\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      s was estimated, and the severities of three clinical signs of\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      were assessed: distribution, erythema and thickness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was a strong correlation between\n                      <jats:styled-content style=\"fixed-case\">AKASI<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">PGA<\/jats:styled-content>\n                      scores (Pearson correlation coefficient: 0.86).\n                      <jats:styled-content style=\"fixed-case\">AKASI<\/jats:styled-content>\n                      was able to discriminate between different\n                      <jats:styled-content style=\"fixed-case\">PGA<\/jats:styled-content>\n                      categories: mean (\n                      <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>\n                      )\n                      <jats:styled-content style=\"fixed-case\">AKASI<\/jats:styled-content>\n                      increased from 2.88 (1.18) for \u2018light\u2019 to 5.33 (1.48) for \u2018moderate\u2019, 8.28 (1.89) for \u2018severe\u2019, and 8.73 (3.03) for \u2018very severe\u2019\n                      <jats:styled-content style=\"fixed-case\">PGA<\/jats:styled-content>\n                      classification. The coefficient of variation for\n                      <jats:styled-content style=\"fixed-case\">AKASI<\/jats:styled-content>\n                      scores was low and relatively constant across all\n                      <jats:styled-content style=\"fixed-case\">PGA<\/jats:styled-content>\n                      categories.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Actinic keratosis area and severity index is proposed as a new quantitative tool for assessing\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      severity on the head. It may be useful in the future evaluation of new\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      treatments in clinical studies and the management of\n                      <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>\n                      in daily practice.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.14267","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T04:10:41Z","timestamp":1491970241000},"page":"1295-1302","source":"Crossref","is-referenced-by-count":92,"title":["A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index"],"prefix":"10.1111","volume":"31","author":[{"given":"T.","family":"Dirschka","sequence":"first","affiliation":[{"name":"Centroderm Clinic Wuppertal Germany"},{"name":"Faculty of Health University Witten\u2010Herdecke Witten Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pellacani","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Modena and Reggio Emilia Modena Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Micali","sequence":"additional","affiliation":[{"name":"Dermatology Clinic University of Catania Catania Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Malvehy","sequence":"additional","affiliation":[{"name":"Melanoma Unit Dermatology Department Hospital Cl\u00ednic de Barcelona IDIBAPS Universitat de Barcelona Barcelona Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Raras (CIBERER) Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Stratigos","sequence":"additional","affiliation":[{"name":"First Department of Dermatology Andreas Sygros Hospital University of Athens Medical School Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Casari","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Modena and Reggio Emilia Modena Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Centroderm Clinic Wuppertal Germany"},{"name":"Department of Dermatology Ruhr\u2010University Bochum Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Dermatology Monklands Hospital Lanarkshire UK"},{"name":"University of Glasgow Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Athens AK Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-015-0070-9"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S31930"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000366525"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12102"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0366-077X.2003.05625.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12848"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910460303"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13180"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70113-G"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07860.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13626"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2012.05776.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12629"},{"key":"e_1_2_6_15_1","first-page":"23","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis","volume":"186","author":"Consensus Report of the European Task Force on Atopic Dermatitis","year":"1993","journal-title":"Dermatology"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546639809160698"},{"key":"e_1_2_6_17_1","unstructured":"US Department of Health and Human Services FaDA.Guidance for industry. Acne vulgaris: developing drugs for treatment. URLhttp:\/\/www.fda.gov\/downloads\/Drugs\/. . .\/Guidances\/UCM071292.pdf(last accessed: December 2016)."},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0404a18"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2006.00355.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12147"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081284"},{"key":"e_1_2_6_23_1","first-page":"224","article-title":"Pemphigus vulgaris activity score and assessment of convergent validity","volume":"51","author":"Chams\u2010Davatchi C","year":"2013","journal-title":"Acta Med Iran"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.051"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01726.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.052"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-013-1413-y"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12591"},{"issue":"1","key":"e_1_2_6_29_1","first-page":"3","article-title":"Actinic keratosis and field cancerisation","volume":"21","author":"Stockfleth E","year":"2011","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.04.012"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.14267","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.14267","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.14267","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.14267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:39:21Z","timestamp":1791279561000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.14267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/jdv.14267"],"URL":"https:\/\/doi.org\/10.1111\/jdv.14267","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]}}}